84-5447-60 [取扱停止]CYFP1 30ul 535278
特徴
- CYFIP1 (cytoplasmic FMR1 interacting protein 1) encodes a protein that regulates cytoskeletal dynamics and protein translation.
- The encoded protein is a component of the WAVE regulatory complex (WRC), which promotes actin polymerization.
- This protein also interacts with the fragile X mental retardation protein (FMRP) and translation initiation factor 4E to inhibit protein translation.
- A large chromosomal deletion including CYFIP1 is associated with increased risk of schizophrenia and epilepsy in human patients.
- Reduced expression of CYFIP1 has been observed in various human cancers and the encoded protein may inhibit tumor invasion.
- CYFIP1 is a protein coding gene.
- Diseases associated with CYFIP1 include fragile X syndrome and schizophrenia.
- Among its related pathways are RET signaling and regulation of actin dynamics for phagocytic cup formation.
- Applications:Suitable for use in Western Blot and ELISA.
- Other applications not tested.
- Recommended Dilution:Western Blot: 1:500-1:2000ELISA: 1:5000-1:20,000Optimal dilutions to be determined by the researcher.
- Storage and Stability:May be stored at 4°C for short-term only.
- Aliquot to avoid repeated freezing and thawing.
- Store at -20°C.
- Aliquots are stable for 12 months after receipt.
- For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
仕様
- Size:30ul
- Host:rabbit
- Source Antibody:human
- Grade:Affinity Purified
- Purity:Purified by immunoaffinity chromatography.
- Form:Supplied as a liquid in PBS, pH 7.4, 0.02% sodium azide, 50% glycerol.
- Specificity:Recognizes endogenous levels of human CYFP1.
- Isotype:IgG
- Calc Applications Abbrev:E WB
- Calc Crossreactivity:Hu
- Immunogen:Synthetic peptide corresponding to aa980-1060 of human CYFP1.
- Swiss Prot Number:Q7L576
- この商品は法規制を確認しておりません。(法規制によって販売できない場合もございます)
- 製品の仕様は予告なく変更になる場合がございます。最新仕様はメーカーホームページをご確認ください。
- 【試薬に関するお問合せ】
- アズワン株式会社 試薬・プロセス材料グループ
- TEL:06-6447-8641
- FAX:06-6447-8642
- E-mail:[email protected]